At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 156 enrolled
Drug / intervention
IW-1973 +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of IW-1973 in Patients With Type 2 Diabetes With Albuminuria Treated With Renin-Angiotensin System Inhibitors
In Brief
A Phase 2 clinical trial evaluating IW-1973 and Placebo for Type 2 Diabetes Mellitus With Diabetic Nephropathy. Completed, enrolled 156 participants across 54 sites.
Detailed Summary
To evaluate the safety and efficacy of IW-1973 in patients with type 2 diabetes mellitus with albuminuria who are on a stable regimen of renin-angiotensin system inhibitors.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsCyclerion Therapeutics
Timeline
Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedJul 2017
Enrollment StartAug 2017
Primary CompletionAug 2019
TodayJul 2026
First PostedJul 14, 2017
Enrollment StartAug 1, 2017
Primary CompletionAug 20, 2019
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 9.0 years ago
Interventions
IW-1973drug
Oral Tablet
IW-1973drug
Oral Tablet
Placebodrug
Oral Tablet